ConductScience.org, home

Paper26344358

Tuning the predictive capacity of the PAMPA-BBB model.

Müller J and 4 others. Eur J Pharm Sci, 2015. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Tuning the predictive capacity of the PAMPA-BBB model. Papers, record 26344358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344358

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tuning the predictive capacity of the PAMPA-BBB model.
PubMed
Journal
Eur J Pharm Sci
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.94
iCite
Revised in PubMed
2015-10-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Müller JJudit
2Esső KKatalin
3Dargó GGergő
4Könczöl ÁÁrpád
5Balogh GTGyörgy T

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood-Brain BarrierMajor topic
Membranes, ArtificialMajor topic
PermeabilityMajor topic
Caco-2 Cells
Humans
Models, Biological
Pharmacokinetics

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42664351The structure of the dopamine D3 receptor bound to cariprazine reveals principles for partial agonists with designed pharmacology.Sci Adv2026https://conductscience.org/library/papers/42664351PubMed
41002483Development of an Innovative Nanosystem Based on Functionalized Albumin and Oxidized Gellan for the Synergistic Delivery of Curcumin and Temozolomide in the Treatment of Brain Cancer.Gels2025https://conductscience.org/library/papers/41002483PubMed
40873686Investigation of blood-brain barrier penetration and pharmacokinetics of a new formulation of cyanide antidote dimethyl trisulfide.Toxicol Environ Health Sci2025https://conductscience.org/library/papers/40873686PubMed
40313508Developing a predictive model for blood-brain-barrier permeability to explore relevance of in vitro neurotoxicity data for in vivo risk assessment.Front Toxicol2025https://conductscience.org/library/papers/40313508PubMed
40025114A high throughput, high content screen for non-toxic small molecules that reduce levels of the nuclear lamina protein, Lamin B1.Sci Rep2025https://conductscience.org/library/papers/40025114PubMed
39479891Characterization of Opioid Agonist Morphine Derivatives with Emphasis on Medicinal Chemistry.ChemMedChem2025https://conductscience.org/library/papers/39479891PubMed
37188705Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models.Nat Commun2023https://conductscience.org/library/papers/37188705PubMed
36986760Natural Lipid Extracts as an Artificial Membrane for Drug Permeability Assay: In Vitro and In Silico Characterization.Pharmaceutics2023https://conductscience.org/library/papers/36986760PubMed
36859418Effect of liposomal formulation of ascorbic acid on corneal permeability.Sci Rep2023https://conductscience.org/library/papers/36859418PubMed
35956776Synthesis, Pharmacokinetic Characterization and Antioxidant Capacity of Carotenoid Succinates and Their Melatonin Conjugates.Molecules2022https://conductscience.org/library/papers/35956776PubMed
35408519Design, Synthesis, and Evaluation of Novel 2H-Benzo[b][1,4]thiazin-3(4H)-one Derivatives as New Acetylcholinesterase Inhibitors.Molecules2022https://conductscience.org/library/papers/35408519PubMed
35298568In vitro and in silico evaluation of Ononis isoflavonoids as molecules targeting the central nervous system.PLoS One2022https://conductscience.org/library/papers/35298568PubMed
34944295New In Vitro Methodology for Kinetics Distribution Prediction in the Brain. An Additional Step towards an Animal-Free Approach.Animals (Basel)2021https://conductscience.org/library/papers/34944295PubMed
34200647Pharmacokinetics-Driven Evaluation of the Antioxidant Activity of Curcuminoids and Their Major Reduced Metabolites-A Medicinal Chemistry Approach.Molecules2021https://conductscience.org/library/papers/34200647PubMed
32302123First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate.J Med Chem2020https://conductscience.org/library/papers/32302123PubMed
32260588In Silico Studies on Triterpenoid Saponins Permeation through the Blood-Brain Barrier Combined with Postmortem Research on the Brain Tissues of Mice Affected by Astragaloside IV Administration.Int J Mol Sci2020https://conductscience.org/library/papers/32260588PubMed
31646222To Pass or Not To Pass: Predicting the Blood-Brain Barrier Permeability with the 3D-RISM-KH Molecular Solvation Theory.ACS Omega2019https://conductscience.org/library/papers/31646222PubMed
31010159Polyphenol Microbial Metabolites Exhibit Gut and Blood⁻Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation.Metabolites2019https://conductscience.org/library/papers/31010159PubMed
30802056Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold.J Med Chem2019https://conductscience.org/library/papers/30802056PubMed
29091437Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker.J Med Chem2017https://conductscience.org/library/papers/29091437PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26344358

GET https://conductscience.org/api/papers/v1/26344358/authors